Diagnosis and Treatment of Polycystic Ovary Syndrome


Polycystic ovary syndrome is the common endocrinopathy among reproductive-aged females in the all over the world, affecting approximately 6% of female patients. The pathophysiology of the disease is complex and there is no single defect from which it is known to result, it is hypothesized that insulin resistance is a key factors from asymptomatic to having multiple gynecologic, dermatologic, or metabolic manifestations. Advices from the Endocrine Society mentioned using the Rotterdam criteria for diagnosis, which mandate the presence of two of the following three findings—hyperandrogenism, ovulatory dysfunction, and polycystic ovaries and plus the exclusion of other diagnoses that could result in ovulatory dysfunction.


    Related Conference of Diagnosis and Treatment of Polycystic Ovary Syndrome

    December 09-10, 2022

    14th International Conference on Gynecology

    Barcelona, Spain
    February 06-07, 2023

    2nd World Congress on Women Health and Gynecology

    Rome, Italy
    February 20-21, 2023

    6th Annual Congress on Polycystic Ovarian Syndrome and Fertility

    Amsterdam, Netherlands
    September 25-26, 2023

    17th International Conferenrce on Genomics & Proetomics

    Las Vegas, USA
    November 06-07, 2023

    10thAsia Pacific Gynecology and Obstetrics Congress

    Tokyo, Japan

    Diagnosis and Treatment of Polycystic Ovary Syndrome Conference Speakers

      Recommended Sessions

      Related Journals

      Are you interested in